
### [NCIT:C4282](http://purl.obolibrary.org/obo/NCIT_C4282)
**Label:** Biphasic Mesothelioma

**Subclasses:** [NCIT:C45665](http://purl.obolibrary.org/obo/NCIT_C45665) (Pleural Biphasic Mesothelioma), 

**Class expressions from DL-Learner:**

- Thing 52.40%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 42.73%
- [NCIT:C36829](http://purl.obolibrary.org/obo/NCIT_C36829) (Abnormal Mesothelial Cell) 42.73%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) 40.91%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 40.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 40.91%


